AMRX FY 2015 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMRXAmneal Pharmaceuticals, Inc.

$4B

FY 2015 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$866M+10.3% YoY

Gross Profit

$499M57.6% margin

Operating Income

$227M26.2% margin

Net Income

$169M19.6% margin

EPS (Diluted)

$0.90

Cash Flow

Operating Cash Flow

$105M

Free Cash Flow

-$12M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$1.2B

Stockholders' Equity

-$195M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$866M	$786M	+10.3%
Gross Profit	$499M	$450M	+11.0%
Operating Income	$227M	$223M	+1.9%
Net Income	$169M	$177M	-4.2%